https://www.sciencedirect.com/science/article/abs/pii/S0929693X20301354?via%3Dihub
https://pubmed.ncbi.nlm.nih.gov/32651146/?utm_source=MS-Office&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1XWEJfKtgOH5BJCB_XVnY7XwqtC08V0cBeD29-y2snwFvl-1ex&fc=20200619141551&ff=20200711065729&v=2.10.1
Short-term efficacy of ORS formulation and propranolol regimen in children with POTS
CONCLUSION: The frequency of syncopal attacks was significantly reduced and the symptom scores for OI were improved in the study group. The improvement in OI symptom scores was better in the treatment group than in the control group. The control group symptoms persisted and caused extreme difficulty in their daily activities. In view of its clinical efficacy, we strongly advocate the use of combined treatment of reduced-osmolarity ORS and low-dose propranolol in pediatric patients with POTS.
pubmed:32651146
pmid:32651146,doi:10.1016/j.arcped.2020.06.001
Date Found:
Sat, 11 Jul 2020 06:00:00 -0400
